Distinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serum

  1. Benoit Vanhollebeke*,
  2. Marianne J. Nielsen,
  3. Yoshihisa Watanabe,
  4. Philippe Truc§,
  5. Luc Vanhamme*,
  6. Kazunori Nakajima,
  7. Soren K. Moestrup, and
  8. Etienne Pays*,
  1. *Laboratory of Molecular Parasitology, Institut de Biologie et de Médecine Moléculaires, Université Libre de Bruxelles, 12, Rue des Profs Jeener et Brachet, B6041 Gosselies, Belgium;
  2. Department of Medical Biochemistry, University of Aarhus, DK-8000 Aarhus, Denmark;
  3. Japanese Red Cross Central Blood Institute, Tokyo 135-8521, Japan;
  4. §Institut de Recherche pour le Développement, Unité de Recherche 117 Trypanosomoses Africaines, Instituto de Combate e Controlo das Tripanosossomiases, CP 2657 Luanda, Angola; and
  5. Tokyo Red Cross Blood Center, Tokyo 135-8639, Japan
  1. Edited by P. Borst, The Netherlands Cancer Institute, Amsterdam, The Netherlands, and approved January 19, 2007 (received for review November 8, 2006)

Abstract

Apolipoprotein L-I (apoL-I) is a human high-density lipoprotein (HDL) component able to kill Trypanosoma brucei brucei by forming anion-selective pores in the lysosomal membrane of the parasite. Another HDL component, haptoglobin-related protein (Hpr), has been suggested as an additional toxin required for full trypanolytic activity of normal human serum. We recently reported the case of a human lacking apoL-I (apoL-I−/−HS) as the result of frameshift mutations in both apoL-I alleles. Here, we show that this serum, devoid of any trypanolytic activity, exhibits normal concentrations of HDL-bound Hpr. Conversely, the serum of individuals with normal HDL-bound apoL-I but who lack Hpr and haptoglobin [Hp(r)−/−HS] as the result of gene deletion (anhaptoglobinemia) exhibited phenotypically normal but delayed trypanolytic activity. The trypanolytic properties of Hp(r)−/−HS were mimicked by free recombinant apoL-I, whereas recombinant Hpr did not affect trypanosomes. The lysis delay observed with either Hp(r)−/−HS or recombinant apoL-I could entirely be attributed to a defect in the uptake of the lytic components. Thus, apoL-I is responsible for the trypanolytic activity of normal human serum, whereas Hpr allows fast uptake of the carrier HDL particles, presumably through their binding to an Hp/Hpr surface receptor of the parasite.

Footnotes

  • To whom correspondence should be addressed. E-mail: epays{at}ulb.ac.be
  • Author contributions: B.V. and E.P. designed research; B.V. performed research; M.J.N., Y.W., P.T., L.V., K.N., and S.K.M. contributed new reagents/analytic tools; B.V. and E.P. analyzed data; and B.V. and E.P. wrote the paper.

  • The authors declare no conflict of interest.

  • This article is a PNAS direct submission.

  • Abbreviations:
    TLF,
    trypanosome lytic factor;
    FCS,
    fetal calf serum;
    NHS,
    normal human serum;
    HDL,
    high-density lipoproteins;
    apoL-I,
    apolipoprotein L-I;
    Hpr,
    haptoglobin-related protein;
    Hp,
    haptoglobin;
    apoA-I,
    apolipoprotein A-I;
    Hp(r)−/−HS,
    human serum devoid of Hp and Hpr;
    apoL-I−/−HS,
    human serum devoid of apoL-I.
« Previous | Next Article »Table of Contents